Personal information

Genetics, statistics, bioinformatics, R programming
Iran

Biography

PhD.D candidate of Medical Genetic, Mashhad university of medical science, Mashhad, Iran.
Msc of Medical Genetic, Tehran university of medical science, Tehran, Iran.
Bsc of Clinical laboratory sciences, Mazandaran university of medical science, Mazandaran, Iran.

Activities

Education and qualifications (1)

Mashhad University of Medical Sciences: Mashhad, Razavi Khorasan, IR

2017-08-12 to present | PhD candidate (Medical Genetices)
Education
Source: Self-asserted source
Arash Poursheikhani

Works (9)

In Silico and Experimental Analyses of Long Non-coding RNA TMPO-AS1 Expression in Iranian Patients with Gastric Cancer

International Journal of Cancer Management
2023-03-06 | Journal article
Contributors: Elaheh Mohammadali; Reza Safaralizadeh; Arash Poursheikhani; Tooraj Asvadi; Shahram Teimourian; Behzad Baradaran
Source: check_circle
Crossref

Clinicopathological Significance of Long Non-Coding RNA GHET1 in Human Cancers: A Meta-Analysis

Current Pharmaceutical Biotechnology
2020-12-07 | Journal article
Contributors: Arash Poursheikhani; Negin Nokhandani; Hassan Yousefi; Dorsa M. Rad; Amirhossein Sahebkar
Source: check_circle
Crossref

In silico evidence of high frequency of miRNA‐related SNPs in Esophageal Squamous Cell Carcinoma

Journal of Cellular Physiology
2020-02 | Journal article
Contributors: Fatemeh Rafieenia; Mohammad Reza Abbaszadegan; Arash Poursheikhani; Seyedeh Mahya Shariat Razavi; Amir Jebelli; Fatemeh Molaei; Seyed Hamid Aghaee‐Bakhtiari
Source: check_circle
Crossref

Obesity, diabetes and the risk of colorectal adenoma and cancer.

BMC endocrine disorders
2019-10 | Journal article
Contributors: Soltani G; Poursheikhani A; Yassi M; Hayatbakhsh A; Kerachian M; Kerachian MA
Source: Self-asserted source
Arash Poursheikhani via Europe PubMed Central

Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies

IUBMB Life
2019-07-04 | Journal article
Part of ISSN: 1521-6543
Source: Self-asserted source
Arash Poursheikhani

Simulating ATO Mechanism and EGFR Signaling with Fuzzy Logic and Petri Net

Journal of Biomedical Physics and Engineering
2018-10-20 | Journal article
Part of ISSN: 2251-7200
Source: Self-asserted source
Arash Poursheikhani

IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer.

Tumori
2018-07 | Journal article
Contributors: Yousefi H; Momeny M; Ghaffari SH; Parsanejad N; Poursheikhani A; Javadikooshesh S; Zarrinrad G; Esmaeili F; Alishahi Z; Sabourinejad Z et al.
Source: Self-asserted source
Arash Poursheikhani via Europe PubMed Central

Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells

Scientific Reports
2017 | Journal article
EID:

2-s2.0-85017183286

Contributors: Momeny, M.; Sabourinejad, Z.; Zarrinrad, G.; Moghaddaskho, F.; Eyvani, H.; Yousefi, H.; Mirshahvaladi, S.; Poursani, E.M.; Barghi, F.; Poursheikhani, A. et al.
Source: Self-asserted source
Arash Poursheikhani via Scopus - Elsevier

Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells

Scientific Reports
2017 | Journal article
EID:

2-s2.0-85021256505

Contributors: Momeny, M.; Zarrinrad, G.; Moghaddaskho, F.; Poursheikhani, A.; Sankanian, G.; Zaghal, A.; Mirshahvaladi, S.; Esmaeili, F.; Eyvani, H.; Barghi, F. et al.
Source: Self-asserted source
Arash Poursheikhani via Scopus - Elsevier